Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
22 hedge funds and large institutions have $64.9M invested in Augmedix, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
7% less capital invested
Capital invested by funds: $69.5M → $64.9M (-$4.59M)
15% less funds holding
Funds holding: 26 → 22 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
+$719K |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$289K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$233K |
| 4 |
TC
TownSquare Capital
Provo,
Utah
|
+$96.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.13M |
| 2 |
O
OrbiMed
New York
|
-$278K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$85K |
| 4 |
VF
Virtu Financial
New York
|
-$70K |
| 5 |
Millennium Management
New York
|
-$40.2K |
AUGX Hedge Fund Activity: Q1 2022 in Review
22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q1 2022, worth a combined $64.9M — down 6.6% from $69.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of AUGX and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Samjo Capital, opening a new position worth an estimated $719K. The largest seller was Russell Investments Group, exiting entirely with an estimated $1.13M sold.
- 22 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q1 2022, down from 26 in Q4 2021.
- Funds reported $64.9M of Augmedix, Inc. Common Stock stock for Q1 2022, down 6.6% quarter-over-quarter.
- 3 funds opened new Augmedix, Inc. Common Stock positions in Q1 2022 and 7 closed out, a net change of -4 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q1 2022 was Samjo Capital, an estimated $719K added.
- The largest Augmedix, Inc. Common Stock seller in Q1 2022 was Russell Investments Group, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2022.